APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sitagliptin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sitagliptin Industry Growth and Trends Forecast to 2032

19 December 202598 pages

Choose your research edition.

Industry ResearchSitagliptin Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sitagliptin Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Sitagliptin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sitagliptin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Sitagliptin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sitagliptin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sitagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sitagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sitagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sitagliptin include Yonta, Baoling Pharma, Merck, De Xiang Pharmaceutical&Chemicals, Haikang Pharma and Phebra, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sitagliptin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sitagliptin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sitagliptin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sitagliptin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sitagliptin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sitagliptin Market by Company

Yonta

Baoling Pharma

Merck

De Xiang Pharmaceutical&Chemicals

Haikang Pharma

Phebra

Sitagliptin Segment by Type

Injection

Tablets

Sitagliptin Segment by Application

Diabetes

Epilepsy

Others

Sitagliptin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sitagliptin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sitagliptin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sitagliptin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sitagliptin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sitagliptin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Tablets Table 3. Global Sitagliptin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sitagliptin Sales by Type (2021-2026) & (K Units) Table 5. Global Sitagliptin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sitagliptin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sitagliptin Sales Market Share in Value by Type (2021-2026) Table 8. Global Sitagliptin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Sitagliptin Sales by Type (2027-2032) & (K Units) Table 10. Global Sitagliptin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sitagliptin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sitagliptin Sales Market Share in Value by Type (2027-2032) Table 13. Global Sitagliptin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Sitagliptin Sales by Type (2021-2026) & (K Units) Table 15. North America Sitagliptin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sitagliptin Sales by Type (2021-2026) & (K Units) Table 17. Europe Sitagliptin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sitagliptin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Sitagliptin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sitagliptin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Sitagliptin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sitagliptin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Sitagliptin Sales by Type (2021-2026) & (US$ Million) Table 24. Sitagliptin Industry Trends Table 25. Sitagliptin Industry Drivers Table 26. Sitagliptin Industry Opportunities and Challenges Table 27. Sitagliptin Industry Restraints Table 28. Global Sitagliptin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sitagliptin Revenue Market Share by Company (2021-2026) Table 30. Global Sitagliptin Sales by Company (2021-2026) & (K Units) Table 31. Global Sitagliptin Sales Share by Company (2021-2026) Table 32. Global Sitagliptin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Sitagliptin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sitagliptin Major Company Production Sites and Headquarters Table 35. Global Sitagliptin Company, Product Type & Application Table 36. Global Sitagliptin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sitagliptin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sitagliptin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sitagliptin Sales by Region (2021-2026) & (K Units) Table 41. Global Sitagliptin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sitagliptin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sitagliptin Sales Market Share in Value by Region (2021-2026) Table 44. Global Sitagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Sitagliptin Sales by Region (2027-2032) & (K Units) Table 46. Global Sitagliptin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sitagliptin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sitagliptin Sales Market Share in Value by Region (2027-2032) Table 49. Global Sitagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Sitagliptin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sitagliptin Sales by Application (2021-2026) & (K Units) Table 52. Global Sitagliptin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sitagliptin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sitagliptin Sales Market Share in Value by Application (2021-2026) Table 55. Global Sitagliptin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Sitagliptin Sales by Application (2027-2032) & (K Units) Table 57. Global Sitagliptin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sitagliptin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sitagliptin Sales Market Share in Value by Application (2027-2032) Table 60. Global Sitagliptin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Sitagliptin Sales by Application (2021-2026) & (K Units) Table 62. North America Sitagliptin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sitagliptin Sales by Application (2021-2026) & (K Units) Table 64. Europe Sitagliptin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sitagliptin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Sitagliptin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sitagliptin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Sitagliptin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sitagliptin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Sitagliptin Sales by Application (2021-2026) & (US$ Million) Table 71. Yonta Company Information Table 72. Yonta Business Overview Table 73. Yonta Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yonta Sitagliptin Product Portfolio Table 75. Yonta Recent Development Table 76. Baoling Pharma Company Information Table 77. Baoling Pharma Business Overview Table 78. Baoling Pharma Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Baoling Pharma Sitagliptin Product Portfolio Table 80. Baoling Pharma Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck Sitagliptin Product Portfolio Table 85. Merck Recent Development Table 86. De Xiang Pharmaceutical&Chemicals Company Information Table 87. De Xiang Pharmaceutical&Chemicals Business Overview Table 88. De Xiang Pharmaceutical&Chemicals Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. De Xiang Pharmaceutical&Chemicals Sitagliptin Product Portfolio Table 90. De Xiang Pharmaceutical&Chemicals Recent Development Table 91. Haikang Pharma Company Information Table 92. Haikang Pharma Business Overview Table 93. Haikang Pharma Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Haikang Pharma Sitagliptin Product Portfolio Table 95. Haikang Pharma Recent Development Table 96. Phebra Company Information Table 97. Phebra Business Overview Table 98. Phebra Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Phebra Sitagliptin Product Portfolio Table 100. Phebra Recent Development Table 101. North America Sitagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Sitagliptin Sales by Country (2021-2026) & (K Units) Table 103. North America Sitagliptin Sales Market Share by Country (2021-2026) Table 104. North America Sitagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Sitagliptin Sales Market Share Forecast by Country (2027-2032) Table 106. North America Sitagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Sitagliptin Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Sitagliptin Market Share by Country (2021-2026) Table 109. North America Sitagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Sitagliptin Market Share Forecast by Country (2027-2032) Table 111. Europe Sitagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Sitagliptin Sales by Country (2021-2026) & (K Units) Table 113. Europe Sitagliptin Sales Market Share by Country (2021-2026) Table 114. Europe Sitagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Sitagliptin Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Sitagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Sitagliptin Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Sitagliptin Market Share by Country (2021-2026) Table 119. Europe Sitagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Sitagliptin Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Sitagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Sitagliptin Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Sitagliptin Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Sitagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Sitagliptin Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Sitagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Sitagliptin Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Sitagliptin Market Share by Country (2021-2026) Table 129. Asia-Pacific Sitagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Sitagliptin Market Share Forecast by Country (2027-2032) Table 131. Latin America Sitagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Sitagliptin Sales by Country (2021-2026) & (K Units) Table 133. Latin America Sitagliptin Sales Market Share by Country (2021-2026) Table 134. Latin America Sitagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Sitagliptin Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Sitagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Sitagliptin Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Sitagliptin Market Share by Country (2021-2026) Table 139. Latin America Sitagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Sitagliptin Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Sitagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Sitagliptin Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Sitagliptin Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Sitagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Sitagliptin Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Sitagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Sitagliptin Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Sitagliptin Market Share by Country (2021-2026) Table 149. Middle East and Africa Sitagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Sitagliptin Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Sitagliptin Distributors List Table 154. Sitagliptin Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Sitagliptin Image Figure 2. Global Sitagliptin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sitagliptin Market Size (2021-2032) & (US$ Million) Figure 4. Global Sitagliptin Sales (2021-2032) & (K Units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablets Image Figure 8. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Sitagliptin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sitagliptin Market Share by Type 2025 VS 2032 Figure 11. North America Sitagliptin Sales Market Share in Volume by Type in 2025 Figure 12. North America Sitagliptin Sales Market Share in Value by Type in 2025 Figure 13. Europe Sitagliptin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sitagliptin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sitagliptin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sitagliptin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sitagliptin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sitagliptin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sitagliptin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sitagliptin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sitagliptin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Diabetes Image Figure 24. Global Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 25. Epilepsy Image Figure 26. Global Epilepsy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Sitagliptin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Sitagliptin Market Share by Application 2025 VS 2032 Figure 31. North America Sitagliptin Sales Market Share in Volume by Application in 2025 Figure 32. North America Sitagliptin Sales Market Share in Value by Application in 2025 Figure 33. Europe Sitagliptin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Sitagliptin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Sitagliptin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Sitagliptin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Sitagliptin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Sitagliptin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Sitagliptin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Sitagliptin Sales Market Share in Value by Application in 2025 Figure 41. North America Sitagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Sitagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Sitagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sitagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Sitagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Sitagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sitagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Sitagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Sitagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sitagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Sitagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Sitagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sitagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Sitagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sitagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Sitagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Sitagliptin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Sitagliptin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablets
Applications
  • Diabetes
  • Epilepsy
  • Others
Companies covered
  • Yonta
  • Baoling Pharma
  • Merck
  • De Xiang Pharmaceutical&Chemicals
  • Haikang Pharma
  • Phebra

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sitagliptin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sitagliptin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sitagliptin Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Tablets
  8. 1.4 Global Sitagliptin Market Size by Type
  9. 1.4.1 Global Sitagliptin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sitagliptin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sitagliptin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sitagliptin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sitagliptin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sitagliptin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sitagliptin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sitagliptin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sitagliptin Industry Trends
  2. 2.2 Sitagliptin Industry Drivers
  3. 2.3 Sitagliptin Industry Opportunities and Challenges
  4. 2.4 Sitagliptin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sitagliptin Revenue (2021-2026)
  2. 3.2 Global Top Players by Sitagliptin Sales (2021-2026)
  3. 3.3 Global Top Players by Sitagliptin Price (2021-2026)
  4. 3.4 Global Sitagliptin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sitagliptin Major Company Production Sites & Headquarters
  6. 3.6 Global Sitagliptin Company, Product Type & Application
  7. 3.7 Global Sitagliptin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sitagliptin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sitagliptin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sitagliptin Tier 1, Tier 2, and Tier 3
4 Sitagliptin Regional Status and Outlook
  1. 4.1 Global Sitagliptin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sitagliptin Historic Market Size by Region
  3. 4.2.1 Global Sitagliptin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sitagliptin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sitagliptin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sitagliptin Forecasted Market Size by Region
  7. 4.3.1 Global Sitagliptin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sitagliptin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sitagliptin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sitagliptin by Application
  1. 5.1 Sitagliptin Market by Application
  2. 5.1.1 Diabetes
  3. 5.1.2 Epilepsy
  4. 5.1.3 Others
  5. 5.2 Global Sitagliptin Market Size by Application
  6. 5.2.1 Global Sitagliptin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Sitagliptin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Sitagliptin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Sitagliptin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Sitagliptin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Sitagliptin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Sitagliptin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Sitagliptin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yonta
  2. 6.1.1 Yonta Company Information
  3. 6.1.2 Yonta Business Overview
  4. 6.1.3 Yonta Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yonta Sitagliptin Product Portfolio
  6. 6.1.5 Yonta Recent Developments
  7. 6.2 Baoling Pharma
  8. 6.2.1 Baoling Pharma Company Information
  9. 6.2.2 Baoling Pharma Business Overview
  10. 6.2.3 Baoling Pharma Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baoling Pharma Sitagliptin Product Portfolio
  12. 6.2.5 Baoling Pharma Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Sitagliptin Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 De Xiang Pharmaceutical&Chemicals
  20. 6.4.1 De Xiang Pharmaceutical&Chemicals Company Information
  21. 6.4.2 De Xiang Pharmaceutical&Chemicals Business Overview
  22. 6.4.3 De Xiang Pharmaceutical&Chemicals Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 De Xiang Pharmaceutical&Chemicals Sitagliptin Product Portfolio
  24. 6.4.5 De Xiang Pharmaceutical&Chemicals Recent Developments
  25. 6.5 Haikang Pharma
  26. 6.5.1 Haikang Pharma Company Information
  27. 6.5.2 Haikang Pharma Business Overview
  28. 6.5.3 Haikang Pharma Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Haikang Pharma Sitagliptin Product Portfolio
  30. 6.5.5 Haikang Pharma Recent Developments
  31. 6.6 Phebra
  32. 6.6.1 Phebra Company Information
  33. 6.6.2 Phebra Business Overview
  34. 6.6.3 Phebra Sitagliptin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Phebra Sitagliptin Product Portfolio
  36. 6.6.5 Phebra Recent Developments
7 North America by Country
  1. 7.1 North America Sitagliptin Sales by Country
  2. 7.1.1 North America Sitagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sitagliptin Sales by Country (2021-2026)
  4. 7.1.3 North America Sitagliptin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sitagliptin Market Size by Country
  6. 7.2.1 North America Sitagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sitagliptin Market Size by Country (2021-2026)
  8. 7.2.3 North America Sitagliptin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sitagliptin Sales by Country
  2. 8.1.1 Europe Sitagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sitagliptin Sales by Country (2021-2026)
  4. 8.1.3 Europe Sitagliptin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sitagliptin Market Size by Country
  6. 8.2.1 Europe Sitagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sitagliptin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sitagliptin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sitagliptin Sales by Country
  2. 9.1.1 Asia-Pacific Sitagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sitagliptin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sitagliptin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sitagliptin Market Size by Country
  6. 9.2.1 Asia-Pacific Sitagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sitagliptin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sitagliptin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sitagliptin Sales by Country
  2. 10.1.1 South America Sitagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sitagliptin Sales by Country (2021-2026)
  4. 10.1.3 South America Sitagliptin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sitagliptin Market Size by Country
  6. 10.2.1 South America Sitagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sitagliptin Market Size by Country (2021-2026)
  8. 10.2.3 South America Sitagliptin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sitagliptin Sales by Country
  2. 11.1.1 Middle East and Africa Sitagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sitagliptin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sitagliptin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sitagliptin Market Size by Country
  6. 11.2.1 Middle East and Africa Sitagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sitagliptin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sitagliptin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sitagliptin Value Chain Analysis
  2. 12.1.1 Sitagliptin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sitagliptin Production Mode & Process
  7. 12.2 Sitagliptin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sitagliptin Distributors
  10. 12.2.3 Sitagliptin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst